. Our first goal was to determine if vascular Isolated uterine vascular beds from virgin and pregnant reactivity in the isolated, perfused uterine vascular bed is rats were used to assess vascular reactivity and the ability altered by the oestrous cycle phase or pregnancy. of nitric oxide (NO), prostanoids and endothelium-derived
Introduction and in pregnant rats (gestation day 17). The contribution of the endothelium-derived products-NO, prostanoids and In females, the fluctuations of sex hormones during the reproductive cycle and pregnancy are known to exert a dramatic EDHF-as mediators of ACh-induced vascular relaxation was also explored. In pregnant females, there is reduced contraction impact on the homeostasis of the cardiovascular system. During normal pregnancy, there is a profound remodelling of the to vasoconstrictors which is thought to be secondary to increased synthesis of NO and prostaglandin I 2 (PGI 2 ) cardiovascular system, characterized by an increase in plasma volume and cardiac output that is accompanied by a decrease (Magness et al., 1992; Kim et al., 1994) and possibly EDHF (Keyes et al., 1998) . Therefore, the ability of a selective in vascular resistance. The uterine vascular control mechanisms are poorly understood, especially how these mechanisms are α 1 -adrenergic agonist, cirazoline (CRZ), to induce tone was also assessed, as well as the influence of NO, prostanoids and EDHF on this CRZ-induced tone.
Materials and methods
Virgin female Sprague-Dawley rats weighing 200-225 g (Harlan, Indianapolis, IN, USA) were housed in a temperature-and humiditycontrolled room of our AALAC approved animal care facility with a 12 h light:12 h dark cycle. The animals had access to distilled water and rat chow ad libitum. A vaginal smear was performed daily before 9:00 a.m. to determine the stage of oestrous cycle. Vaginal smears were examined and vaginal cytology used to determine oestrous stage by the commonly used method (Baker, 1979) . Animals were monitored for at least two oestrous cycles, and only those animals exhibiting regular 4-day oestrous cycles were used in this study. An animal was mated when her vaginal smear indicated that she was in proestrous. The day that spermatozoa were present in the vaginal smear was considered to be day 1 of pregnancy. Female virgin rats on each day of the oestrous cycle (oestrous, Figure 1 . Representative tracing from a time control experiment. dioestrous day-1, dioestrous day-2, proestrous) and pregnant rats on
The responsiveness to acetylcholine (ACh) was tested repeatedly in an isolated, perfused uterine vascular bed taken from a rat in gestation day 17 were used in this study. Following anaesthesia with dioestrous day-1. Tone was induced with cirazoline (1 µmol/l) an i.p. injection of ketamine (37.5 mg/kg) combined with xylazine during the entire protocol. Segment A is analogous to the control (5.0 mg/kg), the abdominal cavity was opened and one uterine response in Figures 3-5; segment B was obtained 20 min after the horn isolated from any connective tissues. The anterior iliac artery, highest concentration of ACh in segment A; segment C was hypogastric artery and uterine neck and vesical artery branches of obtained 20 min after the highest concentration of ACh in segment the uterine artery were ligated, and the uterus perfused through a B; segment D was obtained 40 min after the highest concentration catheter placed in the common iliac artery. The ovarian artery and of ACh in segment C. Sodium nitroprusside (SNP) was given as a vein were cut at the neck of the uterus. The uterine horn was flushed bolus injection after the last injection of ACh. Similar results were with heparinized physiological saline solution (PSS) and transferred obtained in tissues taken from pregnant animals. Scale of tracing is to a warmed chamber. The isolated uterine horn was then perfused in mmHg. with PSS (2 ml/min) using a peristaltic pump (Masterflex, ColePalmer Instruments Co., Vernon Hills, IL, USA). Changes in perfusion developed tone had plateaued, a concentration-response relationship pressure were recorded via a Statham pressure transducer (model to ACh (10 -9 to 10 -5 µmol) was established by giving bolus injections P23XL; Grass, Quincy, PA, USA) coupled to a Grass polygraph (0.1 ml) of ACh into the perfusion tube. After the tissue had recovered recorder (model 7H; Grass). This surgery was modified from that from the highest concentration of ACh, L-NA was added to the described previously (Langer et al., 1993) . perfusion solution (PSS) and co-infused with CRZ. After 20 min, the The composition of our PSS (in mmol/l) was: NaCl 118, KCl 4.7, bolus injections of ACh were repeated. IBU was then added to the CaCl 2 2.5, KH 2 PO 4 1.2, MgSO 4 1.2, NaHCO 3 12.5, glucose 11.1. perfusion solution already containing CRZ and L-NA. After the tone The pH of the PSS was maintained at 7.4 after saturation with reached a plateau (usually 20 min), ACh injections were given for a carbogen (95% O 2 /5% CO 2 ). Tissues were allowed to equilibrate for third time. Finally, TBA was added to the perfusion solution along at least 30 min before the start of the protocol.
with the CRZ, L-NA and IBU and again after tone levelled off All protocols involved measuring vascular reactivity in the absence, (usually 40 min), the ACh injections repeated. Sodium nitroprusside and in the presence of inhibitors of nitric oxide synthase (NOS), (SNP, 1 µmol/l) was administered at the end of each protocol to test cyclo-oxygenase and K ϩ channels, or combinations of these agents.
the viability of the vessels. The preparation was always allowed to Vascular tone in the isolated, perfused uterine vascular bed was return to its pre-injection pressure before another concentration of generated by continuous infusion of CRZ, an α 1 -adrenergic agonist.
ACh or an inhibitor was given. CRZ produces stable tone for many hours in this preparation (Adeagbo One group of virgin rats on dioestrous day-1 and one group of and Triggle, 1993). pregnant rats were subjected to the protocol without addition of L-NA, IBU or TBA to the perfusion medium. These groups served Protocol 1 as time controls, and the response to ACh was virtually identical in all four curves obtained ( Figure 1 ). The purpose of this series of experiments was two-fold. The first was to determine the pressor effect of CRZ infusion and the relative The increase in perfusion pressure (tone) generated by CRZ and any change in tone produced by L-NA, IBU and TBA were compared modulation of this by NO, prostanoids and K ϩ channels (EDHF). NOS was inhibited with N-nitro-L-arginine (L-NA, 100 µmol/l), for the different stages of oestrous cycle and the pregnant group. Concentration-response curves for the response to ACh were concyclo-oxygenase inhibition was achieved with ibuprofen (IBU, 10 µmol/l), and K ϩ channel blockade with tetrabutylammonium (TBA, structed in the presence of CRZ (control), CRZ and L-NA (L-NA present), CRZ, L-NA and IBU (IBU present) and CRZ, L-NA, IBU 100 µmol/l). The second purpose of these experiments was to determine the influence of the oestrous cycle and pregnancy on AChand TBA (TBA present). induced dilatation and the relative contribution of NO, prostanoids Protocol 2 and EDHF in mediating this response. To achieve this goal, one uterine horn was removed and perfused as described above.
The purpose of protocols 2 and 3 was to determine if the order in which inhibitors were added to the perfusion solution affected the Following the equilibration period, CRZ (1 µmol/l) was added to the perfusion medium and retained for the entire protocol. Once the vascular response to ACh. To address this concern, the order in which the inhibitors were added to the perfusion medium was changed, and reactivity to ACh tested in isolated perfused uterine vascular beds from dioestrous day-2 virgin rats and pregnant rats on gestation day 17. After the control curves for the ACh (10 -9 to 10 -5 µmol) had been constructed in the presence of CRZ, IBU (10 µmol/l) was added into the perfusion medium. After the tone reached a plateau, the concentration-response curve to ACh was repeated. After the tissue had recovered from the highest concentration of ACh, L-NA (100 µmol/l) was then added to the perfusion solution (PSS) and coinfused with CRZ and IBU. After 20 min, the bolus injections of ACh were repeated. Finally, TBA (1 mmol/l) was added to the perfusion solution along with the CRZ, IBU and L-NA and again after the tone had levelled off (usually 40 min), the ACh injections were repeated. Figure 2 . Change in perfusion pressure in the isolated, perfused Protocol 3 uterine horn to infusion of the α 1 -adrengergic agonist cirazoline In these experiments, TBA was added to the perfusion solution
(1 µmol/l) in pregnant and cycling rats. The response of the prior to L-NA. In isolated, perfused mesenteries from pregnant and pregnant group (Preg) to cirazoline was significantly different from that of the proestrous group (Proest). Groups with the same letter dioestrous day-1 virgin animals, CRZ (1 µmol/l) was added to the designation are not significantly different from one another; P Ͻ perfusion solution to induce vascular tone. Bolus injections of ACh 0.05. Oestr ϭ oestrus; D-1 ϭ dioestrous day-1; D-2 ϭ dioestrous were given in increasing concentrations (10 -9 to 10 -5 µmol) into day-2. the perfusion tube to determine the control concentration-response relationship. Then, the K ϩ channel blocker, TBA (1 mmol/l) was introduced into the perfusion solution, and after a 40 min equilibration of virgin (n ϭ 4) and a group of pregnant rats (n ϭ 4). In period, ACh responsiveness was determined again. Next, the NOS both groups, the response to ACh was similar in all four inhibitor L-NA (100 µmol/l) was introduced into the suffusion curves. A representative tracing is shown in Figure 1. solution, in addition to CRZ and TBA. After at least a 20 min equilibration period, the vascular responsiveness to ACh was tested
Cirazoline-induced tone and its modulation by L-NA, IBU
again.
and TBA
In all protocols, SNP (1 µmol/l) was injected at the end of each Continuous infusion of CRZ (1 µmol/l) produced a significant experiment to assess the ability of the vessel to dilate. The tissue was increase in perfusion pressure in all experimental groups; always allowed to return to its pre-injection pressure before another concentration of ACh or an inhibitor was given.
however, the increase was significantly smaller in the pregnant group compared with the proestrous group (Figure 2) . The ACh, followed by dioestrous day-1 and dioestrous day-2, Relaxation to ACh at each concentration was expressed as a percentage of the total developed tone (% maximum relaxation). Each concentrapresenting as the second and third most reactive groups tion-response curve was used to determine the concentration of ACh respectively. The proestrous and oestrous groups showed the that gave the maximal response and 50% of the maximal response least sensitivity to ACh, and a comparison of a sensitivity (EC50). Change in perfusion pressure, EC50 and responses at each measure (pEC50) did not show significant difference between concentration of ACh were each compared by one-way analysis of these two groups (Table I) . variance (ANOVA) followed by Newman-Keul's multiple range tests
In the presence of L-NA, there was a significant attenuation when a significant difference existed between groups. P Ͻ 0.05 was of the response to ACh in the oestrous, dioestrous day-2, taken as significant. Group data were reported as mean Ϯ SEM.
proestrous and pregnant groups (Figure 3 , L-NA present). Furthermore. L-NA did not cause a significant change in the Results response to ACh in isolated, perfused uterine vascular beds Establishment of tissue viability over time removed from rats in dioestrous day-1. The addition of IBU to the perfusion medium resulted in a further decrease of the The ability of the isolated, perfused uterine vasculature to respond to repeated application of ACh was tested in a group ACh-induced vasodilatation in the pregnant group. However, no significant changes in the ACh reactivity were observed CRZ caused a significant reduction of the ACh-relaxing properties in pregnant, but not in virgin (dioestrous day-2), Figure 3 . Response of the isolated, perfused uterine horn from pregnant and cycling rats to acetylcholine (ACh) injection. ACh was injected in increasing concentrations into the perfusion line. Data are plotted as the percentage of the maximal relaxation. The curves were performed in succession. Control curves were performed in the presence of cirazoline only (1 µmol/l). N-nitro-L-arginine (L-NA; 100 µmol/l) was then added to the perfusion medium and the responsiveness to ACh tested again (L-NA present). Ibuprofen (IBU; 10 µmol/l) was added to the physiological saline solution (PSS) for the third curve (IBU present) and then tetrabutylammonium (TBA; 1 mmol/l) for the last curve (TBA present). * indicates that the value is significantly different from the control value. # indicates that the value is significantly different from control and L-NA values. ϩ indicates that the value is significantly different from all other groups. P Ͻ 0.05 was taken as significant. n indicates the number of uterine horns in each group. percentage of the maximal relaxation. The curves were performed pregnant and cycling rats to acetylcholine (ACh). ACh was injected in succession. Control curves were performed in the presence of as a bolus into the perfusion line. Data are plotted as the cirazoline only (1 µmol/l). Tetrabutylammonium (1 mmol/l) was percentage of the maximal relaxation. The curves were performed then added to the perfusion medium and the responsiveness to ACh in succession. Control curves were performed in the presence of tested again (TBA present) . N-nitro-L-arginine (L-NA; 100 µmol/l) cirazoline only (1 µmol/l). Ibuprofen (IBU; 10 µmol/l) was then was added to the physiological saline solution (PSS) for the final added to the perfusion medium and the responsiveness to ACh curve (L-NA present). * indicates that the value is significantly tested again (IBU present) . N-nitro-L-arginine (L-NA; 100 µmol/l) different from the control value. # indicates that the value is was added to the physiological saline solution (PSS) for the third significantly different from control and TBA values. P Ͻ 0.05 was curve (L-NA present) and then tetrabutylammonium (TBA; taken as significant. n indicates the number of uterine horns in each 1 mmol/l) for the last curve (TBA present). * indicates that the group. value is significantly different from the control value. # indicates that the value is significantly different from control and IBU values. ϩ indicates that the value is significantly different from all other groups. P Ͻ 0.05 was taken as significant. n indicates the the order in which the inhibitors were added to the perfusion number of uterine horns in each group. solution affected the endothelial mediators released by ACh, TBA was added to the perfusion solution prior to any other animals ( Figure 4, IBU present) . The presence of L-NA in the inhibitors in this protocol. perfusion medium caused a further reduction of the ACh When TBA was introduced into the perfusion solution response in the pregnant group, and also inhibited AChcontaining CRZ only (protocol 3), it caused a marked reduction induced relaxation in the virgin group (Figure 4 , L-NA present).
in ACh-induced dilatation of the uterine vascular beds from As seen in protocol 1, TBA in the perfusion medium caused both pregnant and virgin dioestrous day-1 rats ( Figure 5 , TBA almost complete elimination of the dilatation induced by ACh Present). Addition of L-NA to the perfusion solution containing (Figure 4 , TBA present).
TBA caused a further significant attenuation of the response at the highest dose of ACh ( Figure 5 , L-NA Present).
Protocol 3
To test the ability of the uterine vascular beds to relax at the end of each experiment, a bolus injection of the endotheliumIn all experimental groups in protocols 1 and 2, responsiveness of the uterine vasculature to ACh was virtually abolished by independent relaxing factor, SNP (1 µmol/l) was injected. In all experiments, SNP produced maximal relaxation (100% of the K ϩ channel blocker, TBA, in the presence of L-NA and IBU (Figures 3 and 4, TBA present) . In order to determine if total induced tone; see Figure 1 , SNP injection).
Discussion 5, TBA curves), revealed a marked inhibition of the ACh response by the K ϩ channel blocker alone, reinforcing the Decreased sensitivity to vasoconstrictors and an enhanced concept of a role for K ϩ channels in the relaxation of the responsiveness to endogenous vasodilators are two of the uterine vasculature to ACh in pregnancy, as well as in all the dramatic vascular changes that the uterus undergoes during phases of the oestrous cycle. pregnancy (Lindheimer and Katz, 1992; Ni et al., 1997) . In ACh may have activated K ϩ channels through several the present study, the isolated uterine vasculature from pregnant mechanisms that included: (i) release of EDHF; (ii) stimulation rats had a significantly smaller increase in tone compared of K ϩ channels by NO; and (iii) ACh acting directly on K ϩ with the virgin proestrous group. In addition, in the uterine channels in the vascular smooth muscle cell. This last possibilvasculature from pregnant animals there was a greater sensitivity is unlikely since in uterine preparations in which the ity to ACh than in all the virgin groups.
endothelium was damaged by air embolism, the response NOS activity may be enhanced during pregnancy (Nathan to ACh was always vasoconstriction (N.L.Aslip, personal et al., 1995; Nelson et al., 1998) . The refractoriness to observation). Two pieces of evidence suggest that NO was not vasoconstrictors during pregnancy may be the result of this responsible for activating K ϩ channels. On dioestrous day-1, increased NO activity (White et al., 1998) . Inhibition of NOS inhibition with the NOS inhibitor did not significantly alter in pregnant animals results in sustained hypertension and the response to ACh (see Figure 3 ). In addition, application reversal of the refractoriness to vasoconstrictors such as of the NO donor SNP caused complete relaxation of the uterine angiotensin II (Lubarsky et al., 1997) . Our results are in vasculature, even in the presence of the K ϩ channel blocker agreement with the concept that, during pregnancy, there is an TBA. Thus, it is likely that the endothelium was releasing increase in NO activity. The responsiveness of pregnant rats EDHF in response to ACh. EDHF exerts its vasodilatory effect to ACh was markedly decreased after addition of the NOS by opening the ATP-sensitive K ϩ channel (Richer et al., 1990 ) inhibitor L-NA into the perfusion medium, and to a much and other K ϩ channels, such as the calcium-activated K ϩ larger extent than in the virgin groups (Figure 3) .
channel (Khan et al., 1993) , which causes membrane hyperpolAlthough our results suggest that there is an increase in NO arization. In studies with pregnant and non-pregnant guinea activity in the pregnant uterus, the present data reveal that NO pigs, it was suggested (Keyes et al., 1998) that an increase in is not the only mediator of ACh-induced dilatation of the K ϩ ATP channel activity in the uterine vasculature is involved uterine vascular bed in the pregnant animal. Responsiveness in the modulation of uterine vascular resistance, and opposes to ACh was decreased after addition of IBU into the perfusion angiotensin II-induced uteroplacental vasoconstriction. medium in the pregnant group, either in the presence or Others have reported that neither prostaglandins nor K ϩ absence of a NOS inhibitor (see Figures 3 and 4) . This suggests channels play a role in ACh-induced relaxation of uterine that cyclo-oxygenase activity is also increased in the uterine artery rings from either humans (Jovanović et al., 1994a) or vasculature of pregnant animals. The uterus can synthesize guinea pigs (Jovanović et al., 1995) . Since we are measuring prostaglandins that can alter vascular resistance. Prostacyclin entire uterine vascular bed resistance changes, the discrepancies production is increased in uterine arteries from pregnant between our data and those reported by Jovanović and colsubjects (Wang et al., 1991) , and this is related to the increased leagues may just be due to the difference in large versus small blood flow to the uteroplacental unit (Boura et al., 1994) . It vessel control mechanisms. EDHF plays a larger role in the was reported (Janowiak et al., 1998) that the pregnancymesentery in the smaller (resistance) vessels than in larger induced increase in prostacyclin production by uterine artery vessels (Shimokawa et al., 1996; Takamura et al., 1999) ; thus is associated with a dramatic increase in the expression of we may be seeing a similar situation in the uterine vasculature. cyclo-oxygenase-1 messenger RNA. Thus, it is likely that The sensitivity to ACh changed with the phases of the the inhibition of the ACh-induced dilatation of the uterine oestrous cycle, as well as with pregnancy. The EC50, when vasculature from pregnant rats by IBU is due to the inhibition taken as a measure of sensitivity, showed that the uterine of endothelium-derived prostacyclin formation.
vasculature from rats in the dioestrous day-1 group were the Our results also suggested that K ϩ channels play a major most responsive of the virgin groups. The dioestrous day-2 role in the uterine vasculature. In the presence of L-NA and group was the next most sensitive, followed by the proestrous IBU, the K ϩ channel blocker, TBA, virtually abolished the and oestrous groups. This demonstrated that the uterine vasresponse to ACh. Although TBA is thought predominantly to culature response to ACh, an endothelium-dependent vasodilblock 'big' Ca 2ϩ -dependent K ϩ channels at lower concenator, is cycle day-dependent. This finding suggested that on trations, in the concentration used in the current study proestrous and oestrous, the uterine vasculature is the least (1 mmol/l), TBA was probably a non-specific blocker of all responsive to endothelium-dependent vasodilatation. Since K ϩ channels (Amano et al., 1999; Andriambeloson et al., reproductive hormone concentrations peak during proestrous 1999; Kaw and Hecker, 1999; Okawa et al., 1999; Takamura (Freeman, 1988) , this is the opposite of what one would expect et Vedernikov et al., 2000) . This suggests that based on the studies of the uterine vasculature in pregnancy although NO and perhaps prostacyclin are important mediators where increased hormone concentrations seem to enhance of ACh dilatation in the uterine vasculature during pregnancy, a endothelium-dependent vasodilator responses (Weiner et al., non-NO, non-prostanoid-activated K ϩ channel also contributes. 1991) . Further studies are needed to discover which factor(s) Our results from protocol 3, in which reactivity to ACh was is(are) responsible for the cycle day differences in the response to ACh in the uterine vascular bed. determined in the presence of TBA but not L-NA (see Figure In contrast to our results, Jovanović and co-workers did not
